PHF6 suppresses self-renewal of leukemic stem cells in AML.
Sapana S JalnapurkarAishwarya S PawarSubin S GeorgeCharles AntonyPatrick SomersJason GranaVictoria K FeistSandeep K GurbuxaniVikram R ParalkarPublished in: Leukemia (2024)
Acute myeloid leukemia is characterized by uncontrolled proliferation of self-renewing myeloid progenitors accompanied by a differentiation arrest. PHF6 is a chromatin-binding protein mutated in myeloid leukemias, and its isolated loss increases mouse HSC self-renewal without malignant transformation. We report here that Phf6 knockout increases the aggressiveness of Hoxa9-driven AML over serial transplantation, and increases the frequency of leukemia initiating cells. We define the in vivo hierarchy of Hoxa9-driven AML and identify a population that we term the "LIC-e" (leukemia initiating cells enriched) population. We find that Phf6 loss expands the LIC-e population and skews its transcriptome to a more stem-like state; concordant transcriptome shifts are also observed on PHF6 knockout in a human AML cell line and in PHF6 mutant patient samples from the BEAT AML dataset. We demonstrate that LIC-e accumulation in Phf6 knockout AML occurs not due to effects on cell cycle or apoptosis, but due to an increase in the fraction of its progeny that retain LIC-e identity. Our work indicates that Phf6 loss increases AML self-renewal through context-specific effects on leukemia stem cells.
Keyphrases
- acute myeloid leukemia
- stem cells
- cell cycle
- allogeneic hematopoietic stem cell transplantation
- cell cycle arrest
- induced apoptosis
- gene expression
- signaling pathway
- binding protein
- endoplasmic reticulum stress
- cell proliferation
- genome wide
- endothelial cells
- cell death
- single cell
- wild type
- long non coding rna
- preterm infants
- rna seq
- bone marrow
- pi k akt
- mesenchymal stem cells
- dna damage
- acute lymphoblastic leukemia
- blood pressure